AU7025700A - Polymorphisms in a klotho gene - Google Patents

Polymorphisms in a klotho gene

Info

Publication number
AU7025700A
AU7025700A AU70257/00A AU7025700A AU7025700A AU 7025700 A AU7025700 A AU 7025700A AU 70257/00 A AU70257/00 A AU 70257/00A AU 7025700 A AU7025700 A AU 7025700A AU 7025700 A AU7025700 A AU 7025700A
Authority
AU
Australia
Prior art keywords
polymorphisms
klotho gene
klotho
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70257/00A
Inventor
Mathias Chiano
Kazuhide Hasegawa
Yasuhiro Kikuchi
Helen Molloy
Hirofumi Nakano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921485.0A external-priority patent/GB9921485D0/en
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU7025700A publication Critical patent/AU7025700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
AU70257/00A 1999-09-10 2000-09-08 Polymorphisms in a klotho gene Abandoned AU7025700A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9921485.0A GB9921485D0 (en) 1999-09-10 1999-09-10 Polymorphisms in a klotho gene
GB9921485 1999-09-10
GB0006171 2000-03-14
GB0006171A GB0006171D0 (en) 1999-09-10 2000-03-14 Polymorphisms in a klotho gene
PCT/GB2000/003457 WO2001020031A2 (en) 1999-09-10 2000-09-08 Polymorphisms in a klotho gene

Publications (1)

Publication Number Publication Date
AU7025700A true AU7025700A (en) 2001-04-17

Family

ID=26243878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70257/00A Abandoned AU7025700A (en) 1999-09-10 2000-09-08 Polymorphisms in a klotho gene

Country Status (4)

Country Link
EP (1) EP1210426A2 (en)
JP (1) JP2003514513A (en)
AU (1) AU7025700A (en)
WO (1) WO2001020031A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112075D0 (en) * 2001-05-17 2001-07-11 Univ Aberdeen Diagnostic method for osteoporosis and related disorders
JP4696294B2 (en) * 2004-08-30 2011-06-08 学校法人慶應義塾 Evaluation method, human estrogen receptor gene, genomic DNA, and diagnostic marker
PL2550972T3 (en) 2007-04-02 2018-08-31 Genentech, Inc. A Klotho-beta agonist antibody for use in the treatment of diabetes mellitus or insulin resistance
US20100330062A1 (en) * 2007-05-08 2010-12-30 Koeffler H Phillip Klotho protein and related compounds for the treatment and diagnosis of cancer
US10555963B2 (en) 2007-05-08 2020-02-11 Tel Hashomer Medical Research Infrastructure And Services Ltd. Klotho protein and related compounds for the treatment and diagnosis of cancer
WO2010064247A1 (en) 2008-12-03 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for determining predisposition to cancer
WO2010131704A1 (en) 2009-05-13 2010-11-18 塩野義製薬株式会社 Test agent for visceral obesity and use thereof
CN102465182A (en) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 Detection kit for skin-active ingredients and method for detecting skin-active ingredients by using the same
TWI728373B (en) 2013-12-23 2021-05-21 美商建南德克公司 Antibodies and methods of use
WO2017019957A2 (en) 2015-07-29 2017-02-02 Ngm Biopharmaceuticals, Inc. Binding proteins and methods of use thereof
CN106957921B (en) * 2017-05-18 2020-12-29 中国水产科学研究院珠江水产研究所 SNP locus suitable for klotho gene of micropterus salmoides fed with artificial compound feed and application of SNP locus in breeding
EA035077B1 (en) * 2017-08-14 2020-04-24 Федеральное Государственное Бюджетное Научное Учреждение "Научно Исследовательский Институт Медицины Труда Имени Академика Н.Ф. Измерова" (Фгбну "Нии Мт") Method for predicting the risk of developing syntrophy of bronchial asthma and metabolic syndrome
EP3879271A1 (en) * 2020-03-10 2021-09-15 SALION GmbH Detection of klotho
US20220008519A1 (en) 2020-07-09 2022-01-13 Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho

Also Published As

Publication number Publication date
WO2001020031A2 (en) 2001-03-22
EP1210426A2 (en) 2002-06-05
JP2003514513A (en) 2003-04-22
WO2001020031A3 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU7920500A (en) Conditional sterility in wheat
AU2002256018A1 (en) Overall risk in a system
AU6227000A (en) Straw in a bottle
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU7025700A (en) Polymorphisms in a klotho gene
AUPP995799A0 (en) Improvements in hinges
AUPQ262599A0 (en) Gene expression
AU7119400A (en) Single nucleotide polymorphisms in genes
AU1645700A (en) Oenothein medicaments
AU7317300A (en) Light-responsive oligonucleotide
AU1584300A (en) A multi-cage lift in pair
AU2732000A (en) Reverse gene therapy
AU2258601A (en) Ibd-related polymorphisms
AU2153401A (en) Gene expression in biological conditions
AU5008000A (en) Molecules expressed in hippocampus
AU1873201A (en) Interferon-alpha induced gene
AU1992900A (en) Docking arrangement
AU6871900A (en) Tsg-like gene
GB0006171D0 (en) Polymorphisms in a klotho gene
AU1316500A (en) Improvements in bead construction
AU7447600A (en) Antiobestic agents
AU4367900A (en) Carbohydrate-modifying enzymes
AU1348601A (en) Modular computer
GB2355348B (en) Improvements in connectors
AU5852000A (en) Atopy gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase